
51 - 200 funcionários
Fundada em 2019
🏥 Saúde
🧬 Biotecnologia
💊 Farmacêutico
Healthcare • Biotechnology • Pharmaceuticals
A Definium Therapeutics é uma empresa de biotecnologia em estágio clínico, desenvolvendo terapias de precisão derivadas de psicodélicos para distúrbios psiquiátricos e neurodesenvolvimentais. A empresa foca em formulações farmacêuticas otimizadas de lisergida (LSD) e um R-enantiômero de MDMA para tratar condições como transtorno depressivo maior, transtorno de ansiedade generalizada e sintomas centrais do transtorno do espectro autista, avançando candidatos através de ensaios pré-clínicos e clínicos com uma abordagem científica e baseada em evidências.
🕒 Agosto 26
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $215.000 - $250.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
👻 Score fantasma 5%
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
Fundada em 2019
🏥 Saúde
🧬 Biotecnologia
💊 Farmacêutico
Healthcare • Biotechnology • Pharmaceuticals
A Definium Therapeutics é uma empresa de biotecnologia em estágio clínico, desenvolvendo terapias de precisão derivadas de psicodélicos para distúrbios psiquiátricos e neurodesenvolvimentais. A empresa foca em formulações farmacêuticas otimizadas de lisergida (LSD) e um R-enantiômero de MDMA para tratar condições como transtorno depressivo maior, transtorno de ansiedade generalizada e sintomas centrais do transtorno do espectro autista, avançando candidatos através de ensaios pré-clínicos e clínicos com uma abordagem científica e baseada em evidências.
• Develop and execute end-to-end strategies for Expanded Access Programs and late-stage studies across Definium’s portfolio • Lead global Expanded Access Program and late-stage development strategy aligned with asset lifecycle objectives, patient access goals, and regulatory expectations • Partner with cross-functional teams to integrate Expanded Access Program and late-stage clinical activities into overall asset strategy • Lead Expanded Access Program development and implementation, including protocol development, eligibility criteria, safety oversight, and operational execution • Ensure Expanded Access Programs are compliant, scalable, ethically sound, and aligned with regulatory guidance • Consult on benefit-risk assessment, safety monitoring, and ongoing program evaluation • Support late-stage clinical evidence generation strategy, including real-world evidence, long-term safety, effectiveness, and treatment differentiation • Lead design, planning, and execution of Phase 4 and investigator-initiated clinical evidence programs • Ensure program designs address regulatory commitments, payer needs, and scientific gaps • Collaborate on clinical content for regulatory submissions and interactions • Provide clinical input into Investigator Brochures and clinical study reports • Work with Clinical Operations, Clinical Development, Data Management, Biostatistics, Pharmacovigilance, and Project Management to ensure high-quality execution • Maintain relationships with investigators, advisors, and external experts • Provide clinical leadership within matrix teams
• Doctoral degree required (MD, PhD, PharmD, PsyD) • 6-8+ years of clinical development experience in the pharmaceutical or biotechnology industry • Demonstrated experience leading Expanded Access programs and late-stage, post-approval programs • Experience selecting and managing third-party vendors to support operational functions of Expanded Access and late-stage evidence programs • CNS clinical development experience in psychiatry strongly preferred • Experience with budget ownership to include forecasting tracking, and managing across multiple programs • Working knowledge of expanded access program requirements, clinical development, regulatory pathways, and lifecycle management • Proven ability to translate strategy into execution in resource-constrained environments • Track record of effective cross-functional leadership and external stakeholder engagement • Ability to operate with diplomacy, influence without authority, and command credibility with senior leaders and external experts • Excellent verbal and written communication skills • Self-motivated, adaptable, and comfortable balancing strategic thinking with hands-on contribution • Comfortable rolling up sleeves while maintaining a strategic perspective • Energized by innovation in clinical research and patient-centric access models • Thrives in a fast-paced, evolving environment with high accountability • Acts as a role model for scientific excellence, integrity, and collaboration
• 100% paid health benefits including Medical, Dental and Vision for you and your dependents • 401(k) program with company match and vesting after the turn of the first month after your start date • Flexible time off • Generous parental leave and some fun fringe perks! • Additional compensation, including bonus and equity may be available
Candidatar-se🕒 Agosto 26
Portfolio Manager expanding ICF’s FEMA Public Assistance and Recovery business across designated U.S. regions. Leading capture strategy, client acquisition, proposals, and growing portfolio delivery.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $131.256 - $223.134 / ano
💰 $30.000.000 Grant em 2021-03
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Agosto 26
Portfolio Manager leading FEMA Region 4 Public Assistance delivery and growth. Managing disaster recovery clients, Project Managers, P&L, and regional proposal pursuits.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $131.256 - $223.134 / ano
💰 $30.000.000 Grant em 2021-03
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Agosto 26
Director of Payments scaling CARET Pay, embedded payments integrated into legal practice management software. Owning go-to-market strategy, merchant activation, P&L, and processor relationships.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Agosto 26
Solution Development Director validating and sizing new healthcare payer/provider opportunities for Vatica Health. Building board-ready investment cases before handoff to Solutions for development.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $150.000 - $175.000 / ano
💰 $1.200.000 Venture Round em 2013-11
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Agosto 26
ThinkWell health financing director leading global technical programs, talent development, and portfolio growth. Advising governments, donors, and partners on public financial management and domestic resource mobilization.
🗣️🇺🇸🇬🇧 Inglês obrigatório